These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 12401161)

  • 1. Prevention and treatment of osteoporosis in postmenopausal women.
    French L; Smith M; Shimp L
    J Fam Pract; 2002 Oct; 51(10):875-82. PubMed ID: 12401161
    [No Abstract]   [Full Text] [Related]  

  • 2. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmenopausal osteoporosis and alendronate.
    Pérez-López FR
    Maturitas; 2004 Jul; 48(3):179-92. PubMed ID: 15207883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention and treatment of osteoporosis--have we come any further? A cross-sectional study of hospitalized patients].
    Lundsgaard C; Dufour N; Perrild HJ; Schwarz P
    Ugeskr Laeger; 2000 Aug; 162(32):4274-7. PubMed ID: 10962949
    [No Abstract]   [Full Text] [Related]  

  • 5. Osteoporosis: prevention with estrogens in women over 60.
    Palacios S
    Maturitas; 1999 Sep; 33(1):1-6. PubMed ID: 10585170
    [No Abstract]   [Full Text] [Related]  

  • 6. Who will benefit from treatment with selective estrogen receptor modulators (SERMs)?
    Sambrook P
    Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):975-81. PubMed ID: 16301191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Osteoporotic fracture in menopausal women: alendronate reduces the risk].
    Bize R; Lamy O; Peytremann-Bridevaux I
    Rev Med Suisse; 2008 Dec; 4(183):2703. PubMed ID: 19157286
    [No Abstract]   [Full Text] [Related]  

  • 8. Fracture prevention in postmenopausal women.
    Mosekilde L; Vestergaard P; Langdahl B
    Am Fam Physician; 2008 May; 77(10):1447-8. PubMed ID: 18533379
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention, diagnosis, and management of osteoporosis-related fracture.
    Fakih M
    J Am Osteopath Assoc; 2009 Mar; 109(3):191-3. PubMed ID: 19336772
    [No Abstract]   [Full Text] [Related]  

  • 10. Strontium: new drug. Postmenopausal osteoporosis: too many unknowns.
    Prescrire Int; 2005 Dec; 14(80):207-11. PubMed ID: 16397977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical inquiries. What is the best approach to prevention and treatment of osteoporosis?
    Schwartz K; Chang SI
    J Fam Pract; 2001 Dec; 50(12):1024-5. PubMed ID: 11742601
    [No Abstract]   [Full Text] [Related]  

  • 12. Osteoporosis in postmenopausal women. Therapy options across a wide range of risk for fracture.
    Miller RG
    Geriatrics; 2006 Jan; 61(1):24-30. PubMed ID: 16405361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone mineral density thresholds for pharmacological intervention to prevent fractures.
    Siris ES; Chen YT; Abbott TA; Barrett-Connor E; Miller PD; Wehren LE; Berger ML
    Arch Intern Med; 2004 May; 164(10):1108-12. PubMed ID: 15159268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bone mineral density measurements for diagnosis of osteoporosis and the risk assessment].
    Kushida K
    Clin Calcium; 2004 Dec; 14(12):11-7. PubMed ID: 15577168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do not use bisphosphonate therapy indefinitely for fracture prevention.
    Prescrire Int; 2008 Oct; 17(97):214. PubMed ID: 19536944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of women at risk for fracture and intervention with fast-acting therapies.
    Derman R
    Int J Fertil Womens Med; 2006; 51(4):183-90. PubMed ID: 17184104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term estrogen and hormone replacement therapy for the prevention and treatment of osteoporosis.
    Levine JP
    Curr Womens Health Rep; 2003 Jun; 3(3):181-6. PubMed ID: 12734027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ["European Guidance 2008" for the diagnosis and management of postmenopausal osteoporosis--what is new and clinically relevant?].
    Bartl R;
    Dtsch Med Wochenschr; 2009 Jan; 134(3):92-4. PubMed ID: 19142840
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention and treatment of osteoporosis in primary care offices.
    Gill JM; Hoffman MK
    J Womens Health (Larchmt); 2003 Jun; 12(5):473-80. PubMed ID: 12869294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ipriflavone not effective for osteoporosis.
    Harv Womens Health Watch; 2001 Jun; 8(10):5. PubMed ID: 11439282
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.